COMPUESTOS DERIVADOS DE TRIAZOL/ISOXAZOL-METOXINAFTIRIDINA SUSTITUIDOS Y PIRIDO[3,4-C]PIRIDAZINA ÚTILES PARA EL TRATAMIENTO DE ENFERMEDADES RELACIONADAS CON EL RECEPTOR GABA a5

La presente invención proporciona compuestos de Ia fórmula (I) ESPACIO PARA FÓRMULA , que tienen afinidad y selectividad por el receptor A subunidad α5 del ácido γ-aminobutírico (GABAA α5) y actúan como moduladores alostéricos positivos GABAA α5 ( GABAA α5 PAM), útiles en el tratamiento o Ia prevenc...

Full description

Saved in:
Bibliographic Details
Main Authors Kapus, Gábor László, Szabó, György, Potor, Attila, Túrós, György István, Éliás, Olivér, Vágó, István
Format Patent
LanguageSpanish
Published 11.05.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract La presente invención proporciona compuestos de Ia fórmula (I) ESPACIO PARA FÓRMULA , que tienen afinidad y selectividad por el receptor A subunidad α5 del ácido γ-aminobutírico (GABAA α5) y actúan como moduladores alostéricos positivos GABAA α5 ( GABAA α5 PAM), útiles en el tratamiento o Ia prevención de enfermedades relacionadas con el receptor GABAA α5. The present invention provides compounds of formula (I) and/or salts thereof and/or biologically active metabolites thereof and/or prodrugs thereof and/or solvates thereof and/or hydrates thereof and/or polymorphs thereof having affinity and selectivity for the gamma-aminobutyric acid A receptor subunit alpha 5 and act as GABAA α5 positive allosteric modulators, thereby useful in the treatment or prevention of diseases related to the GABAA α5 receptor, process for the preparation and intermediates of the preparation process thereof, pharmaceutical compositions comprising them alone or in combination with one or more other active ingredients and their use as medicaments.
AbstractList La presente invención proporciona compuestos de Ia fórmula (I) ESPACIO PARA FÓRMULA , que tienen afinidad y selectividad por el receptor A subunidad α5 del ácido γ-aminobutírico (GABAA α5) y actúan como moduladores alostéricos positivos GABAA α5 ( GABAA α5 PAM), útiles en el tratamiento o Ia prevención de enfermedades relacionadas con el receptor GABAA α5. The present invention provides compounds of formula (I) and/or salts thereof and/or biologically active metabolites thereof and/or prodrugs thereof and/or solvates thereof and/or hydrates thereof and/or polymorphs thereof having affinity and selectivity for the gamma-aminobutyric acid A receptor subunit alpha 5 and act as GABAA α5 positive allosteric modulators, thereby useful in the treatment or prevention of diseases related to the GABAA α5 receptor, process for the preparation and intermediates of the preparation process thereof, pharmaceutical compositions comprising them alone or in combination with one or more other active ingredients and their use as medicaments.
Author Túrós, György István
Potor, Attila
Szabó, György
Kapus, Gábor László
Éliás, Olivér
Vágó, István
Author_xml – fullname: Kapus, Gábor László
– fullname: Szabó, György
– fullname: Potor, Attila
– fullname: Túrós, György István
– fullname: Éliás, Olivér
– fullname: Vágó, István
BookMark eNqNjUFOw0AMRbMoC1q4g7snapRSwdbMOGApGUczDiqtUBWh6apKK5XTcAvOwMXIVByAlZ-t97-n2WQ4DvE6-zbStB0FlQCWPL-ivRCoZ9xIveAg6wR5Qyprdlgpe7YjQOiCsnacEm_QprNsl3f3uXm_LLhJ1s-Xck0BWvQIVI_FqNgwOZX0h1xFviGLdnQ81WhYHFoMYMQl35OhVsXDMz4h9Kub7GrfH87x9m_OsnlFal7yeDru4vnUf8Qhfu5MVxZlWRSrR3xY_sf5BUS8TKY
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID CU20220058A7
GroupedDBID EVB
ID FETCH-epo_espacenet_CU20220058A73
IEDL.DBID EVB
IngestDate Fri Jul 26 04:29:42 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Spanish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CU20220058A73
Notes Application Number: CU20220000058
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230511&DB=EPODOC&CC=CU&NR=20220058A7
ParticipantIDs epo_espacenet_CU20220058A7
PublicationCentury 2000
PublicationDate 20230511
PublicationDateYYYYMMDD 2023-05-11
PublicationDate_xml – month: 05
  year: 2023
  text: 20230511
  day: 11
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies RICHTER GEDEON NYRT
RelatedCompanies_xml – name: RICHTER GEDEON NYRT
Score 3.3122451
Snippet La presente invención proporciona compuestos de Ia fórmula (I) ESPACIO PARA FÓRMULA , que tienen afinidad y selectividad por el receptor A subunidad α5 del...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title COMPUESTOS DERIVADOS DE TRIAZOL/ISOXAZOL-METOXINAFTIRIDINA SUSTITUIDOS Y PIRIDO[3,4-C]PIRIDAZINA ÚTILES PARA EL TRATAMIENTO DE ENFERMEDADES RELACIONADAS CON EL RECEPTOR GABA a5
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230511&DB=EPODOC&locale=&CC=CU&NR=20220058A7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fT8IwEG8QjfqmqFH8k5oYniTIGGw-EFPaTmrYumwdQYwhG38SfQAiGL-L38LP4BfzOkF80Zfl1nbXrJfb3e-6uyJ0ASayZg3K5jc2MSumXbSNSgwXQER9MynHaejC9WrNyLzrVDsZ9LzMhUnrhL6lxRFBo_qg7_P0ez1dBbFY-m_lrJQ8QdPkxlF1VligY_CnwYEosEad-5JJWqC0TqOCF-g-HT-xibWG1rUbrevs83ZDZ6VMf5sUZwdt-MBtPN9FmeEsh7bo8uS1HNp0FxveQC50b7aHPqh0_YiHSoaYAfxqE5ZSWAWCdGWrJELZ0UTR5Up2hEccJQLBgMBhFCqhIqGfuMe-bpYPlUuzSB_TG9LVoz7flWjxEPskIJi3gDFRxBXcU1LPwz2HBy5nILsQ66M2qK6jy0iIqfT0-IBT7isZ4FvSIDiu7qNzhyvaLMK7934Wukej1TJVDlB2PBkPDxEe2XHfspLE0Gmr_WsjGQAKAk_RAIUfja7sI5T_m0_-v85jtK2Fpnfjy-UTlJ2_vA5PwcjPk7NUOl_9nJ3u
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fT8IwEG8QjfimqFH8VxPDkwSBweYDMaXtpLqty9YZxBjC-JPoAxDB-F38Fn4Gv5jXCeKLviy3trtmvdzuftfdFaEzMJE1s18yvrGJUTGsglWudOECiKhnxKVuErpwvVozMm5a1VYKPS9yYZI6oW9JcUTQqB7o-yz5Xk-WQSyW_Fs5LcZP0DS-slWd5efoGPxpcCDyrFHnvmSS5imt0yjvBbpPx08sYq6gVVNX59Wu011DZ6VMfpsUexOt-cBtNNtCqcE0izJ0cfJaFq278w1vIOe6N91GH1S6fsRDJUPMAH7dEZZQWAWCtKVTFKFsaaLgciVbwiO2EoFgQOAwCpVQkdBP3GNfN8uHyrlRoI_JDWnrUZ_vSjg8xD4JCOYOMCaKuIJ7Sup5uGfzwOUMZBdifdQG1XV0GQkxlZ4eH3DKfSUDfE0aBHerO-jU5oo2C_DunZ-F7tBouUyVXZQejUeDPYSHVrdnmnFc1mmrvcty3AcUBJ5iGRR-OLyw9lHubz65_zpPUKapXKfjCO_2AG1oAeqd-VLpEKVnL6-DIzD4s_g4kdQXi0Og2w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPUESTOS+DERIVADOS+DE+TRIAZOL%2FISOXAZOL-METOXINAFTIRIDINA+SUSTITUIDOS+Y+PIRIDO%5B3%2C4-C%5DPIRIDAZINA+%C3%9ATILES+PARA+EL+TRATAMIENTO+DE+ENFERMEDADES+RELACIONADAS+CON+EL+RECEPTOR+GABA+a5&rft.inventor=Kapus%2C+G%C3%A1bor+L%C3%A1szl%C3%B3&rft.inventor=Szab%C3%B3%2C+Gy%C3%B6rgy&rft.inventor=Potor%2C+Attila&rft.inventor=T%C3%BAr%C3%B3s%2C+Gy%C3%B6rgy+Istv%C3%A1n&rft.inventor=%C3%89li%C3%A1s%2C+Oliv%C3%A9r&rft.inventor=V%C3%A1g%C3%B3%2C+Istv%C3%A1n&rft.date=2023-05-11&rft.externalDBID=A7&rft.externalDocID=CU20220058A7